Yousif Capital Management LLC Cuts Stock Holdings in Cardinal Health, Inc. (NYSE:CAH)

Yousif Capital Management LLC lowered its position in Cardinal Health, Inc. (NYSE:CAH) by 4.2% in the 4th quarter, HoldingsChannel.com reports. The firm owned 110,599 shares of the company’s stock after selling 4,879 shares during the period. Yousif Capital Management LLC’s holdings in Cardinal Health were worth $13,081,000 as of its most recent SEC filing.

A number of other large investors also recently made changes to their positions in CAH. Avitas Wealth Management LLC purchased a new stake in Cardinal Health in the 4th quarter valued at about $1,466,000. E. Ohman J or Asset Management AB grew its holdings in shares of Cardinal Health by 15.0% in the fourth quarter. E. Ohman J or Asset Management AB now owns 11,500 shares of the company’s stock valued at $1,360,000 after acquiring an additional 1,500 shares in the last quarter. Patron Partners LLC increased its position in shares of Cardinal Health by 6.1% during the fourth quarter. Patron Partners LLC now owns 2,043 shares of the company’s stock valued at $242,000 after acquiring an additional 117 shares during the last quarter. Columbus Macro LLC lifted its holdings in Cardinal Health by 55.1% during the fourth quarter. Columbus Macro LLC now owns 18,319 shares of the company’s stock worth $2,167,000 after acquiring an additional 6,510 shares during the period. Finally, Resonant Capital Advisors LLC boosted its position in Cardinal Health by 1.9% in the fourth quarter. Resonant Capital Advisors LLC now owns 8,698 shares of the company’s stock worth $1,029,000 after purchasing an additional 160 shares during the last quarter. 87.17% of the stock is owned by institutional investors.

Cardinal Health Price Performance

NYSE CAH opened at $125.29 on Wednesday. The company’s 50 day simple moving average is $122.16 and its two-hundred day simple moving average is $114.75. The stock has a market capitalization of $30.27 billion, a PE ratio of 23.38, a P/E/G ratio of 1.46 and a beta of 0.63. Cardinal Health, Inc. has a 1 year low of $93.17 and a 1 year high of $132.84.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. On average, research analysts anticipate that Cardinal Health, Inc. will post 7.92 EPS for the current year.

Cardinal Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be paid a $0.5056 dividend. This represents a $2.02 dividend on an annualized basis and a yield of 1.61%. The ex-dividend date of this dividend is Tuesday, April 1st. Cardinal Health’s dividend payout ratio is currently 37.69%.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on CAH. Deutsche Bank Aktiengesellschaft lifted their target price on Cardinal Health from $119.00 to $124.00 and gave the stock a “hold” rating in a research note on Monday, November 4th. Wells Fargo & Company raised their price target on shares of Cardinal Health from $135.00 to $136.00 and gave the stock an “equal weight” rating in a research note on Tuesday. Morgan Stanley increased their price objective on Cardinal Health from $136.00 to $142.00 and gave the company an “overweight” rating in a report on Friday, January 31st. UBS Group boosted their target price on Cardinal Health from $134.00 to $139.00 and gave the company a “buy” rating in a research note on Monday, November 4th. Finally, JPMorgan Chase & Co. increased their price target on Cardinal Health from $142.00 to $145.00 and gave the stock a “neutral” rating in a research note on Tuesday. Four investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $135.93.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.